vcfirmsdirectory.com

Venture capital

Kairos Ventures

Kairos Ventures is a Beverly Hills-based venture investor that backs early-stage companies built on patents, ideas and discoveries from leading universities and scientists, across life science and physical science.

Beverly Hills · Pasadena · New York · Washington D.C. · AustinRegistered · Beverly Hills
New investments · 12 months
Fund vehiclesPublic
19
19 active · US private fund
First chequePublic
$150K–$20M
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:05 CETSources: kairosventures.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Kairos Ventures joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Kairos Ventures right for your round?

Is Kairos Ventures a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
19
19 active · US private fund
SEC adviser filings
First chequePublic
$150K–$20M
From the firm’s website
kairosventures.com
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

KAIROS VENTURE PARTNERS II, L.P.US private fund · Active · United States · $60M gross assets · filed 27 Mar 2026
KAIROS VENTURE PARTNERS III, L.P.US private fund · Active · United States · $35.4M gross assets · filed 27 Mar 2026
KAIROS VENTURE OPPORTUNITIES I, L.P.US private fund · Active · United States · $26.1M gross assets · filed 27 Mar 2026
KAIROS VENTURE PARTNERS I, L.P.US private fund · Active · United States · $25.2M gross assets · filed 27 Mar 2026
KAIROS-PROVIVI SPV, L.P.US private fund · Active · United States · $15.4M gross assets · filed 27 Mar 2026
KAIROS-VIVODYNE SPV, L.P.US private fund · Active · United States · $12.8M gross assets · filed 27 Mar 2026
KAIROS SPV FUND LLCUS private fund · Active · United States · $9.1M gross assets · filed 27 Mar 2026
KAIROS-APPLAUD SPV, L.P.US private fund · Active · United States · $5.3M gross assets · filed 27 Mar 2026
KAIROS-FOLDAX SPV, L.P.US private fund · Active · United States · $4.9M gross assets · filed 27 Mar 2026
KAIROS-GURU SPV, L.P.US private fund · Active · United States · $3.7M gross assets · filed 27 Mar 2026
KAIROS-BEST SPV, L.P.US private fund · Active · United States · $3.3M gross assets · filed 27 Mar 2026
KAIROS-AMORPHOLOGY SPV, L.P.US private fund · Active · United States · $1.7M gross assets · filed 27 Mar 2026
7 more fund vehiclesSEC adviser filings
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Kairos Ventures joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Kairos Ventures joined

Round sizes, Kairos Ventures’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

1200 PharmaActiniaActuate TherapeuticsAmorphologyAvvio MedicalBehavioral SignalsChimera BioengineeringClearsenseCytoDelDEARhealthand 19 more

Portfolio and exits

Every company Kairos Ventures backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Kairos Ventures puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Kairos Ventures

Events where Kairos Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Kairos Ventures’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

27 Mar 2026Fund filingForm ADV filed by KAIROS VENTURE INVESTMENTS, LLC: 19 private funds, $208.7M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Kairos Ventures is based in Beverly Hills, United States. It also has offices in Pasadena, New York, Washington D.C. and Austin.

19 fund vehicles are on public registers (SEC adviser filings), including KAIROS VENTURE PARTNERS II, L.P., KAIROS VENTURE PARTNERS III, L.P. and KAIROS VENTURE OPPORTUNITIES I, L.P.

Sectors: Life sciences. From the firm’s own website.

Backs top scientists, engineers and entrepreneurs early, during the formative stage of a company, to turn scientific discoveries into viable businesses quickly. Aims for founding teams to keep majority ownership. From the firm’s own website.

$150K to $20M per investment, according to the firm’s own website.

Kairos Ventures lists 29 portfolio companies on its website, including 1200 Pharma, Actinia, Actuate Therapeutics, Amorphology and Avvio Medical.

Firms whose websites list some of the same companies include Alter Global, Bison Ventures and BOLD Capital Partners.

Know before Kairos Ventures’s next round is announced.

PRO tracks Kairos Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Kairos VenturesGet Kairos Ventures’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.